Feb. 4, 2012 at 8:18pm
Temps PresentsYasminYasminelleYAZBEYAZSAFYRALDROSPIRENONEDRSPDRSP/EEFDASwiss MedicBlood ClotsDeep Vein ThrombosisPulmonary EmboliStrokesCardiac EventsYAZ VICTIMSYAZ LAWSUITSYAZ BLOOD CLOTSYAZ RECALLDRSP RECALL

Temps Presents an investigative report from the award winning Swiss investigative news program on #DRSP (#DROSPIRENONE) containing birth control pills. The documentary profiles the aftermath of events for several YAZ VICTIMS and their stories of survival.

Dec. 8, 2011 at 6:42pm
MARKETPLACEHEALTH CANADAFDADRSPDROSPIRENONEYASMINYAZYAZ vs YASMINYAZ BIRTH CONTROLYAZ LAWSUITSYAZ LAWYERSYAZ SIDE EFFECTSYAZ BLOOD CLOTSDRSP LAWSUITSDRSP CONTAINING BIRTH CONTROLVENOUS THROMBOEMBOLISMVTEPULMONARY EMBOLIPEDEEP VEIN THROMBOSISDVTYAZ vs YASMINYAZ vs BEYAZYAZ vs SAFYRALYAZ vs OCELLAYAZ vs VESTURAYAZ vs ZARAHYAZ RECALLRECALLRECALLS

MARKETPLACE, CANADA’S CONSUMER WATCHDOG, investigates #YASMIN, #YAZ birth control pills that contain #DRSP #DROSPIRENONE. HEALTH CANADA announced this week that it had concluded a ‘safety review’ of the pills and found they presented a 1.5x to 3.0x higher risk of blood clots than other pills. This story was aired prior to this announcement in early 2011. FDA is holding hearings 12.8.11-12.9.11 to consider blood clot risks of these pills and other contraceptives. In May 2011, the EMA (European Medicines Agency) announced the pills presented a 1.5x to 3.0x higher risk of blood clots. FDA funded studies concluded the pills were 74%, or 1.74x. higher risk in comparison to other hormonal contraceptives it considered.

(Source: youtu.be)

5:37pm
FDABAYERFDA WARNING LETTERDRSPDROSPIRENONEYAZYASMINYAZ vs YAZYAZ BLOOD CLOTSYAZ BIRTH CONTROLYAZ vs BEYAZYAZ vs SAFYRALBirth ControlDRSP/EEEthinyl Estradiol3mg DRSPDRSP (DROSPIRENONE)

FDA required corrective ads, or ‘clear up’, following FDA WARNING LETTERS involving DRSP (DROSPIRENONE) pills and their direct to consumer promotion.

(Source: youtu.be)